Expanded Access Program for Pirtobrutinib for Participants With B-Cell Cancer

Conditions:   Leukemia, Lymphocytic, Chronic, B-Cell;   Lymphoma, Lymphocytic, Small;   Lymphoma, Mantle-Cell;   Waldenstrom Macroglobulinemia;   Ritcher's Transformation, Syndrome Intervention:   Drug: Pirtobrutinib Sponsor:   Loxo Oncology, Inc. Available
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials